GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Tax Expense

Guangdong Hybribio Biotech Co (SZSE:300639) Tax Expense : ¥-96.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Tax Expense?

Guangdong Hybribio Biotech Co's tax expense for the months ended in Sep. 2024 was ¥-56.2 Mil. Its tax expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-96.0 Mil.


Guangdong Hybribio Biotech Co Tax Expense Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co Tax Expense Chart

Guangdong Hybribio Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.57 69.32 172.24 326.06 -31.70

Guangdong Hybribio Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.21 -36.25 -5.70 2.15 -56.19

Guangdong Hybribio Biotech Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-96.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Hybribio Biotech Co  (SZSE:300639) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Guangdong Hybribio Biotech Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Executives
Xie Long Xu Directors, executives
Li Qing Hui Executives
Wang Jian Yu Directors, executives
Guan Zhi Sheng Directors, executives
Qiu Mei Lan Supervisors
Yuan Xian Securities Affairs Representative
Tang You Gen Independent director
Cai Dan Ping Director
Chen Yi Directors, executives
Xu Wan Jian Supervisors
Huang Wei Xiong Director
Guan Qiao Zhong Directors, executives

Guangdong Hybribio Biotech Co Headlines

No Headlines